Fong Z, et al. - Authors here planned to assess quality of life (QOL) and functionality in a large cohort of patients ≥5-years after pancreaticoduodenectomy (PD). In this study, the patients demonstrated better global QOL, physical- and role-functioning scores at 5-years when compared with age- and sex-matched controls. Approximately half of the patients were administered pancreatic enzyme replacement, while only 11% developed new-onset diabetes.